These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 26833123)
1. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer. Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123 [TBL] [Abstract][Full Text] [Related]
2. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682 [TBL] [Abstract][Full Text] [Related]
3. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569 [No Abstract] [Full Text] [Related]
4. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene. Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143 [TBL] [Abstract][Full Text] [Related]
5. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698 [TBL] [Abstract][Full Text] [Related]
6. Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. Gordon K; Kochkodan JJ; Blatt H; Lin SY; Kaplan N; Johnston A; Swindell WR; Hoover P; Schlosser BJ; Elder JT; Gudjonsson JE; Getsios S J Invest Dermatol; 2013 Mar; 133(3):712-722. PubMed ID: 23190894 [TBL] [Abstract][Full Text] [Related]
7. EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells. Cuyàs E; Queralt B; Martin-Castillo B; Bosch-Barrera J; Menendez JA Oncol Rep; 2017 Jul; 38(1):263-270. PubMed ID: 28560458 [TBL] [Abstract][Full Text] [Related]
8. Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature. Konda N; Saeki N; Nishino S; Ogawa K Histochem Cell Biol; 2017 Mar; 147(3):317-339. PubMed ID: 27665280 [TBL] [Abstract][Full Text] [Related]
9. A conditional feedback loop regulates Ras activity through EphA2. Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464 [TBL] [Abstract][Full Text] [Related]
11. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes. Xu Q; Lin WC; Petit RS; Groves JT Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062 [TBL] [Abstract][Full Text] [Related]
12. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling. Gao Z; Han X; Zhu Y; Zhang H; Tian R; Wang Z; Cui Y; Wang Z; Niu R; Zhang F Cell Death Dis; 2021 Apr; 12(5):414. PubMed ID: 33879771 [TBL] [Abstract][Full Text] [Related]
13. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975 [TBL] [Abstract][Full Text] [Related]
14. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556 [TBL] [Abstract][Full Text] [Related]
15. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Salaita K; Nair PM; Petit RS; Neve RM; Das D; Gray JW; Groves JT Science; 2010 Mar; 327(5971):1380-5. PubMed ID: 20223987 [TBL] [Abstract][Full Text] [Related]
16. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors. Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244 [TBL] [Abstract][Full Text] [Related]
17. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472 [TBL] [Abstract][Full Text] [Related]
18. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550 [TBL] [Abstract][Full Text] [Related]
19. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury. Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118 [TBL] [Abstract][Full Text] [Related]